Month: August 2019

QuiremScout® superior in predicting intrahepatic dose distribution

In their study, Smits et al. showed that QuiremScout® is a superior predictor of  intrahepatic dose distribution compared to Tech-99m-MAA. The results of their study were published online on the 9th of August 2019 in the European Journal of Nuclear Medicine and Molecular Imaging. With individualized treatment planning becoming increasingly

Read More »